Philip Morris International (PM) Q2 2026 earnings review
Record Revenues Top $11 Billion, But the U.S. Segment Stumbles
Philip Morris delivered a milestone quarter, surpassing $11 billion in net revenues for the first time (+10.4% YoY). The growth was fueled by exceptional 10% pricing power in combustibles and accelerating International Smoke-Free adoption. Adjusted EPS climbed 15.2% to $2.20, leading management to raise the lower end of its full-year guidance. However, beneath the headline beat lies a sharp deterioration in the U.S. market. ZYN offtake volumes flatlined against tough comps, and U.S. Adjusted Operating Companies Income (OCI) plunged 19% organically as aggressive investments compressed margins by 600 basis points. Furthermore, a $511M non-cash impairment of its Canadian affiliate (RBH) dragged reported EPS into negative territory (-7.7%).
🐂 Bull Case
The International Smoke-Free segment grew revenues 14.2% organically. Gross margins expanded to an impressive 70.1%, demonstrating that scale and mix are structurally elevating the company's profitability profile.
Despite ongoing global volume pressures, PMI achieved an exceptional 10.0% pricing variance in international combustibles, driving 6.4% organic revenue growth in the segment while volume actually ticked up 1.1%.
🐻 Bear Case
The U.S. segment went from being the star growth engine to a major drag. U.S. Adjusted OCI collapsed 19.1% organically as ZYN shipments eked out just 1.8% growth, and heavy footprint investments shredded gross margins from 71.4% down to 65.4%.
Japan's April excise tax hike successfully sapped demand (HTU adjusted IMS down 3.4%). Coupled with a $511M hit from the RBH write-down in Canada, international markets remain fraught with policy risks.
⚖️ Verdict: 🟢
Bullish. While the U.S. stumble and RBH impairment are disappointing, the sheer scale of the $11.2B topline and the relentless pricing power in combustibles comfortably offset regional weaknesses. A 70%+ gross margin in International Smoke-Free is a structural advantage competitors cannot match.
Key Themes
Unrelenting Combustible Pricing Power
The legacy combustible business refuses to fade. Total cigarette volumes grew 1.1%, driven by markets like Turkey, Indonesia, and Egypt. More importantly, PMI extracted an aggressive 10.0% positive pricing variance. This lever drove a 6.4% organic net revenue increase and an 8.0% organic gross profit increase in the segment, continuing to act as a massive cash cow funding the smoke-free transition.
International Smoke-Free Margins Hit 70%
Scale is paying off. The International Smoke-Free segment expanded gross margins by 1.8 percentage points YoY to 70.1%. Revenue surged 14.2% (11.8% organically) fueled by broad-based IQOS strength (HTU shipments +7.6%) outside of Japan and Poland. The category now represents ~42% of total PMI net revenues.
U.S. Segment Profitability Plunges
The most glaring red flag in the quarter is the U.S. segment. Net revenues fell 0.9% organically. ZYN offtake volumes were 'flat to slightly growing', failing to compensate for cigar declines and negative phasing. Worse, U.S. Adjusted Gross Profit margin collapsed by 600 basis points (from 71.4% to 65.4%) due to manufacturing expansion costs, sending Adjusted OCI down 19.1% organically to $279 million. Management claims they will 'accelerate U.S. investments in the second half', meaning margins will likely remain under severe pressure.
ZYN ULTRA and Historic MRTP Authorizations
To combat the U.S. slowdown, PMI executed two major strategic moves. First, the FDA granted Modified Risk Tobacco Product (MRTP) authorization to 20 flagship ZYN variants—the first ever for a nicotine pouch, cementing a massive regulatory moat. Second, PMI launched ZYN ULTRA in June (9mg and 11mg moist variants at a lower price-per-pouch) to compete aggressively in the dynamic high-strength segment. Further 1.5mg and 8mg dry variants are launching in Q3.
Japan Excise Tax Bites Demand
The expected headwind in Japan materialized. Adjusted in-market sales (IMS) for PMI HTUs declined by an estimated 3.4% following the April 1 excise-driven price increase. While management states growth was +1.0% when excluding 'pantry de-loading', it underscores that consumers are price-sensitive. The lower-tier SENTIA brand is now critical to capturing consumers trading down from premium TEREA sticks.
RBH Impairment Slashes Reported Earnings
A non-cash impairment charge of $511 million ($0.33 per share) was recorded against the carrying value of PMI's deconsolidated Canadian affiliate, RBH. The write-down, prompted by 'current industry dynamics' in RBH's updated five-year business plan, dragged PMI's reported Diluted EPS down 7.7% YoY. The remaining carrying value is now a negligible $51 million.
Macro Volatility: Middle East and Currency
Management flagged the Middle East conflict as having a 'minor impact' so far, primarily hitting transport, energy, and input costs. While no discernible shift in consumer behavior is evident yet, the full-year forecast now bakes in higher input costs. Furthermore, currency translational impacts wiped $0.05 off the prior full-year EPS guidance, reflecting a strengthening U.S. dollar against transactional gains.
VEEV E-Vapor Acceleration
Often overshadowed by IQOS and ZYN, VEEV is quietly becoming a powerhouse. Quarterly shipments surged 55.1% YoY to 1.3 billion units. VEEV is now the clear #1 closed pod brand in Europe, driving highly profitable growth in key markets like Germany, Romania, and Greece.
Other KPIs
Accelerating. Up a massive 66.3% from $3.06 billion in the first half of 2025. This exceptional cash generation easily funds the aggressive U.S. footprint expansion while sustaining the dividend, validating the cash-conversion power of the dual combustible/smoke-free model.
Accelerating. Up 55.1% YoY. While small relative to HTUs (41.8B), the explosive growth of VEEV proves PMI's multi-category strategy is successfully capturing the closed-pod e-vapor market in Europe.
Guidance
Accelerating. Management raised the bottom end of the range, projecting 9.5% to 11.5% YoY growth (7.5% to 9.5% excluding currency). This tightens the previous outlook and signals strong confidence in H2 execution despite the U.S. margin drag.
Stable. Represents solid sequential momentum from Q2's $2.20, heavily supported by international combustible pricing and IQOS scale, though it absorbs an estimated $0.08 unfavorable currency impact.
Stable. Reconfirmed. Requires sustained double-digit growth in international smoke-free to offset the expected 2% to 3% decline in global cigarette volumes.
Stable. Reconfirmed. Shows management expects operating leverage to remain positive for the year, largely driven by the accretive 70%+ gross margins in the International Smoke-Free segment offsetting U.S. investment burn.
Key Questions
U.S. Margin Floor
U.S. gross margins plunged 600 basis points to 65.4% this quarter, and you indicated U.S. investments will accelerate in H2. Where is the absolute floor for U.S. margins during this ZYN ULTRA and IQOS ILUMA expansion phase?
ZYN ULTRA Cannibalization vs. Expansion
With the launch of ZYN ULTRA at a lower price-per-pouch to compete in the high-strength segment, what percentage of initial adoption is coming from competitor brands versus trading down from premium, lower-strength flagship ZYN?
RBH Strategic Implications
The $511 million non-cash impairment of the RBH investment points to deteriorating industry dynamics in Canada. Does this alter your long-term view of the Canadian market as a viable geography for future smoke-free investments?
Japan Tax Elasticity
With HTU volumes in Japan shrinking 3.4% post-tax hike, are you seeing permanent category suppression, or is SENTIA successfully catching all the down-trading from TEREA?